Influence of electrolyte balance on the prognosis of long-term cardiovascular events after acute coronary syndrome

Aim. To assess the effect of electrolyte changes on the prognosis of long-term cardiovascular events after acute coronary syndrome (ACS).

Material and methods. The study included 105 patients with ACS who underwent coronary angiography (CA) with coronary stenting. At the study inclusion (before CA with coronary stenting), we collected data on traditional risk factors, analyzed levels of urinary sodium and potassium, kaliuresis and natriuresis. Free water clearance (FWC) and electrolyte free water clearance (EFWC), as well as fluid balance using bioelectrical impedance analysis were determined. Study endpoints (fatal and nonfatal cardiovascular events) were determined 6,2±0,2 months after CA with coronary stenting.

Results. It was found that a decrease in urinary sodium (χ2=5,64, p=0,02, Constanta B0 =-0,62, Estimate =-16,5) and natriuresis (χ²=4,1, р=0,044, Constanta B0 =-1,38, Estimate =-5,2) increase the death risk. Urinary sodium of 0,2 mol/L and natriuresis of 0,5 mol are threshold levels of increased risk of death. Urinary potassium decrease was associated with an increase in death risk (threshold level — 0,5 mol/L, χ2=4,99, р=0,025, Constanta B0 =-0,63, Estimate =-70,4) and acute myocardial infarction (threshold level — 0,06 mol/L, χ2=3,93, р=0,04, Constanta B0 =-0,99, Estimate =-58,0) in the long-term period. Increase in EFWC increased the likelihood of long-term transient ischemic attack after ACS (χ2=4,61, р=0,03, Constanta B0 =-2,95, Estimate =-1,0). There were no significant relationships in the matter of FWC (p>0,05). However, with a decrease in intracellular fluid volume compared to normal values and a decrease in FWC or an increase in EFWC, the likelihood of longterm composite endpoints after ACS increases.

Conclusion. As a result of the study, risk markers for long-term fatal and non-fatal cardiovascular events after ACS were established: decrease in urinary sodium <0,2 mol/l and potassium <0,5 mol/l; decrease in FWC and increase in EFWC with or without cellular dehydration. The established markers can complement the current cardiovascular risk score methods in patients with ACS.

1. Golovinova EO, Batiushin MM, Levitskaya ES, et al. The prognostic value of renal dysfunction and imbalance of the body’s aqueous media in patients with acute coronary pathology. Nephrology. 2017;21(1):39-45. (In Russ.) doi:10.24884/1561-6274-2017-21-1-39-45.

2. Virani SS, Alonso A, Benjamin EJ, et al. Heart Disease and Stroke Statistics — 2020 Update: A Report From the American Heart Association. Circulation. 2020;141(9):е139-е596. doi:10.1161/CIR.0000000000000757.

3. Gulati R, Behfar A, Narula J, et al. Acute Myocardial Infarction in Young Individuals. Mayo Clin Proc. 2020;95(1):136-56. doi:10.1016/j.mayocp.2019.05.001.

4. Levitskaya ES, Batiushin MM, Pasechnik DG, et al. Renal artery remodeling is the initiator and target of the cardiorenal continuum. Cardiovascular Therapy and Prevention. 2015;14(1):90-6. (In Russ.) doi:10.15829/1728-8800-2015-1-90-96.

5. Kong YW, Baqar S, Jerums G, Ekinci EI. Sodium and Its Role in Cardiovascular Disease — The Debate Continues. Front Endocrinol (Lausanne). 2016;7:164. doi:10.3389/fendo.2016.00164.

6. Aburto NJ, Ziolkovska A, Hooper L, et al. Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ. 2013. 3;346:f1326. doi:10.1136/bmj.f1326.

7. O’Donnell M, Mente A, Rangarajan S, et al. Joint association of urinary sodium and potassium excretion with cardiovascular events and mortality: prospective cohort study. BMJ. 2019. 364:l772. doi:10.1136/bmj.l772.

8. Ma Q-Q, Fan X-D, Li T, et al. Short- and long-term prognostic value of hyponatremia in patients with acute coronary syndrome: A systematic review and meta-analysis. PLoS One. 2018;13(3):e0193857. doi:10.1371/journal.pone.0193857.

9. Welsh CE, Welsh P, Jhund P, et al. Urinary Sodium Excretion, Blood Pressure, and Risk of Future Cardiovascular Disease and Mortality in Subjects Without Prior Cardiovascular Disease. Hypertension. 2019;73(6):1202-9. doi:10.1161/HYPERTENSIONAHA.119.12726.

10. Kim E-J, Choi M-J, Lee J-H, et al. Extracellular Fluid/Intracellular Fluid Volume Ratio as a Novel Risk Indicator for All-Cause Mortality and Cardiovascular Disease in Hemodialysis Patients. PLoS One. 2017;12(1):e0170272. doi:10.1371/journal.pone.0170272.

11. Miller WL. Assessment and Management of Volume Overload and Congestion in Chronic Heart Failure: Can Measuring Blood Volume Provide New Insights. Kidney Dis. 2016;2:164-9. doi:10.1159/000450526.